Demerol

Meperidine Hydrochloride · MEPERIDINE HYDROCHLORIDE 75 mg/mL · Injection, Solution · Intramuscular; Intravenous; Subcutaneous · Hospira, Inc.

NDC 00409-1179-30 · 10 CARTRIDGE in 1 CARTON / 1 mL in 1 CARTRIDGE · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built

Data sources

CMS NADAC (pharmacy acquisition, weekly)
CMS Part B ASP quarterly payment limits
CMS Maximum Fair Prices (IRA negotiated, NDC-level)
Medicare Part D Spending by Drug (data.cms.gov, name-matched)
VA FSS / Big4 federal contract prices (va.gov, twice monthly)
ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
California SB-17 WAC filings (list price, per package)

Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Medicare Part B pays (ASP+6%)$6.34per billing unit (100 MG)HCPCS J2175 · Jul 1, 2026
Part D plans paid (avg)$7.38per dosage unitgross, before rebates — matched by drug name · 2024
Federal ceiling (Big4)$46.77per package of 10X1MLPfizer Inc. · Jan 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$63.96

Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 100 MG

$6.339

HCPCS J2175 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2024)

$819

72 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Hospira, Inc.United States
analysis · label · manufacture · pack
Hospira, Inc.
analysis

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $369.36 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application: NDA021171
TE code: AP
Approval date: Jan 1, 1982
Patents / exclusivity: None on file

Shortage history

In shortage now — Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30)May 30, 2025
Other
month 16 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
In shortage now — Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30)May 30, 2025
month 16 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
In shortage now — Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)May 30, 2025
month 16 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
In shortage now — Demerol, Injection, 75 mg/1 mL (NDC 0409-1179-30)May 30, 2025
Discontinuation of the manufacture of the drug
month 16 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Meperidine Hydrochloride (Injection, Solution)

Labeler	Strength	First seen	Last seen
Hospira, Inc.	MEPERIDINE HYDROCHLORIDE 50 mg/mL	Jul 15, 2026	Sep 3, 2026
Hospira, Inc.	MEPERIDINE HYDROCHLORIDE 25 mg/mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	MEPERIDINE HYDROCHLORIDE 75 mg/mL	Jul 15, 2026	Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Demerol — NDC 00409-1179-30," retrieved September 3, 2026, https://drugdashboards.com/drug/00409117930.

Free to cite with attribution — see how the data is put together.